Close Menu

NEW YORK (GenomeWeb News) – Agilent Technologies and BGI announced today an agreement to create a "next-generation super exome."

The deal calls for the partners to develop methodologies for next-generation genome-wide association studies in order to create a super exome that incorporates sequence regions that may be more informative for specific human populations.

The methodologies are expected to help scientists in the areas of disease and drug research, Agilent and BGI said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post writes that the approval in the US of a SARS-CoV-2 vaccine will be up to Peter Marks, a career official at the Food and Drug Administration.

According to ScienceInsider, the US National Academies of Science, Engineering, and Medicine is planning a study of racism in academic research.

NPR reports the US loan to Eastman Kodak to boost domestic pharmaceutical production is on pause following insider trading allegations.

In Cell this week: blood immune cell changes in COVID-19 patients and spatial transcriptomics in Alzheimer's disease.